Your browser doesn't support javascript.
loading
Dupilumab-induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis.
Ryser, Fabio S; Yalamanoglu, Ayla; Valaperti, Alan; Brühlmann, Catrin; Mauthe, Tina; Traidl, Stephan; Soyka, Michael B; Steiner, Urs C.
Affiliation
  • Ryser FS; Department of Rheumatology and Immunology, University Hospital Bern, University of Bern, Bern, Switzerland.
  • Yalamanoglu A; Faculty of Medicine, University of Bern, Bern, Switzerland.
  • Valaperti A; Department of Immunology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Brühlmann C; Department of Immunology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Mauthe T; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Traidl S; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Soyka MB; Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Steiner UC; Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
Allergy ; 78(10): 2712-2723, 2023 10.
Article in En | MEDLINE | ID: mdl-37548395
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Sinusitis / Rhinitis / Nasal Polyps / Eosinophilia Type of study: Prognostic_studies Limits: Humans Language: En Journal: Allergy Year: 2023 Type: Article Affiliation country: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Sinusitis / Rhinitis / Nasal Polyps / Eosinophilia Type of study: Prognostic_studies Limits: Humans Language: En Journal: Allergy Year: 2023 Type: Article Affiliation country: Switzerland